News

TRINOVA-1 signals new direction in ovarian cancer

Publish date: October 4, 2013

 

AT THE EUROPEAN CANCER CONGRESS 2013

pwendling@frontlinemedcom.com

Pages

Recommended Reading

Timely palliative consult affects end-of-life care in gynecologic cancer patients
MDedge Hematology and Oncology
Routine bilateral salpingectomy with hysterectomy gains acceptance
MDedge Hematology and Oncology
CDC urges doctors to help patients quit smoking
MDedge Hematology and Oncology
Maintenance pazopanib delays progression of advanced ovarian cancer
MDedge Hematology and Oncology
Cervical cancer screening with acetic acid saves lives
MDedge Hematology and Oncology
Bevacizumab plus chemotherapy extends cervical cancer survival
MDedge Hematology and Oncology
CDC study finds 56% drop in HPV infections
MDedge Hematology and Oncology
Olaparib maintenance of most benefit in BRCA mutation carriers
MDedge Hematology and Oncology
Weekly chemo offers quality-of-life edge in advanced ovarian cancer
MDedge Hematology and Oncology
Biweekly 5-fluorouracil cream beat back cervical neoplasia
MDedge Hematology and Oncology